Pharmacokinetics of bevacizumab in haemodialysis

被引：1
|
作者：
Garnier-Viougeat, Nathalie [1 ]
Rixe, Olivier
Paintaud, Gilles
Ternant, David
Degenne, Danielle
Mouawad, Roger
Deray, Gilbert
Izzedine, Hassane
机构：
[1] Hop La Pitie Salpetriere, Dept Clin Oncol, Paris, France
[2] Hop La Pitie Salpetriere, Dept Nephrol, Paris, France
[3] Univ Tours, EA 3853, Tours, France
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2007年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：975 / 975
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis
    Pfister, M
    Schaedeli, F
    Frey, FJ
    Uehlinger, DE
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (06) : 645 - 651
  • [42] Pharmacokinetics of Valsartan in Hypertensive Patients on Long-Term Haemodialysis
    Michael F. Leidig
    Christian Delles
    Christian Kuchenbecker
    Rainer-Ainer-Max Lederle
    Gottfried Weidinger
    Roland E. Schmieder
    Clinical Drug Investigation, 2001, 21 : 59 - 66
  • [43] Pharmacokinetics of prostaglandin E1 in patients undergoing haemodialysis
    Cawello, W
    Samadi, N
    Schweer, H
    Wilberz, S
    Kuhlmann, U
    Lange, H
    Seyberth, HW
    VASA-JOURNAL OF VASCULAR DISEASES, 1999, : 17 - 19
  • [44] Population pharmacokinetics of gentamicin in haemodialysis patients: modelling, simulations and recommendations
    Franck, Benedicte
    Monchaud, Caroline
    Saint-Marcoux, Franck
    Rerolle, Jean-Philippe
    Allard, Julien
    Allot, Vincent
    Marquet, Pierre
    Essig, Marie
    Woillard, Jean-Baptiste
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (07) : 947 - 955
  • [45] Pharmacokinetics of valsartan in hypertensive patients on long-term haemodialysis
    Leidig, MF
    Delles, C
    Kuchenbecker, C
    Lederle, XAM
    Weidinger, G
    Schmieder, RE
    CLINICAL DRUG INVESTIGATION, 2001, 21 (01) : 59 - 66
  • [46] Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis
    Spigset, O
    Hägg, S
    Stegmayr, B
    Dahlqvist, R
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (9-10) : 699 - 703
  • [47] Population pharmacokinetics of gentamicin in haemodialysis patients: modelling, simulations and recommendations
    Bénédicte Franck
    Caroline Monchaud
    Franck Saint-Marcoux
    Jean-Philippe Rérolle
    Julien Allard
    Vincent Allot
    Pierre Marquet
    Marie Essig
    Jean-Baptiste Woillard
    European Journal of Clinical Pharmacology, 2020, 76 : 947 - 955
  • [48] Single-dose daptomycin pharmacokinetics in chronic haemodialysis patients
    Salama, Noha N.
    Segal, Jonathan H.
    Churchwell, Mariann D.
    Patel, Jignesh H.
    Gao, Lihong
    Heung, Michael
    Mueller, Bruce A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (04) : 1279 - 1284
  • [49] Apixaban in patients on haemodialysis: a single-dose pharmacokinetics study
    Van den Bosch, Ines
    Bouillon, Thomas
    Verhamme, Peter
    Vanassche, Thomas
    Jacquemin, Marc
    Coemans, Maarten
    Kuypers, Dirk
    Meijers, Bjorn
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (05) : 884 - 889
  • [50] Telaprevir pharmacokinetics in a hepatitis C virus infected patient on haemodialysis
    de Kanter, Clara T. M. M.
    den Hollander, Jan G.
    Verweij-van Wissen, Corrien P. W. G. M.
    Burger, David M.
    JOURNAL OF CLINICAL VIROLOGY, 2014, 60 (04) : 431 - 432
12345